Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3405
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 115 $158,852 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $158,852 Current and potential, with all options
- Last date to order 16% complete
- IDV ceiling <1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
AmerisourceBergen Drug Corp has been awarded a single-award Indefinite Delivery Contract (SPE2DX) by the Defense Logistics Agency Troop Support Medical Supply Chain, valued at $999,999,999.00 with a performance period extending through March 6, 2035. This contract serves as a prime vendor vehicle for comprehensive global pharmaceutical support to Department of Defense customers, including the Defense Health Agency and U.S. Coast Guard. The contract encompasses a broad spectrum of pharmaceutical products and medical supplies, including brand-name and generic medications, specialty pharmaceuticals, vaccines, syringes, vials, medical devices such as auto-injectors, and diagnostic test kits across multiple therapeutic domains. Specific product categories covered include diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, hormone treatments, and other critical medical commodities required to support military healthcare programs worldwide on both a routine and contingency basis.
The contract award originated from a Defense Logistics Agency pre-solicitation notice posted in February 2024 announcing the Pharmaceutical Prime Vendor Global Program Generation V, an estimated $30.3 billion procurement designed to establish multiple regional pharmaceutical supply contracts with a 30-month base period and three 30-month option periods. The solicitation indicated that awards would be made to at least three different contractors on a regional basis covering North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items, with compensation structured through distribution fees for both brand/generic and specialty pharmaceuticals. AmerisourceBergen's award represents its selection as a primary supplier under this competitive, non-set-aside procurement, positioning the company to deliver firm fixed-price delivery orders supporting the full spectrum of military pharmaceutical logistics operations across global customer bases.
Task orders
Show 40 more
Latest 50 of 115 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3405?
SPE2DR25D3405 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 7, 2025.
How much is contract SPE2DR25D3405 worth?
Orders under SPE2DR25D3405 have obligated $158,852. SPE2DR25D3405's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D3405?
115 orders have been placed under SPE2DR25D3405, the latest on July 17, 2026.
Who can order from contract SPE2DR25D3405?
SPE2DR25D3405 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3405 competed?
The extent of competition for SPE2DR25D3405 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV